Filters
Hikma launches Morphine Sulfate Injection, USP, in a prefilled syringe in the US
Press Release, Product
14 July 2025
Supporting communities globally: Highlights from our 2025 Global Volunteer Campaign
Story, Responsibility
03 July 2025
Meet Farah Alasali, Senior Officer in our Social Responsibility team based in Jordan. Hear what she has to say about lif...
Story, Life at Hikma
02 July 2025
New
Hikma receives FDA approval for TYZAVANTM (Vancomycin Injection, USP) in the US
Press Release, Product
02 July 2025
New
Hikma publishes its 2024 Sustainability Report reinforcing commitment to global access to medicines
Press Release, Corporate
30 June 2025
Hikma R&D – Innovating analytical research: meet Samuel Cook
Story, Life at Hikma
30 June 2025
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and dev...
Press Release, Corporate
28 June 2025
New
Inspiring women of Hikma - Meet Judy Bock, Associate Director, Quality Assurance
Story, Leadership
27 June 2025
New
Hikma launches Methylene Blue Injection, USP in the US
Press Release, Product
25 June 2025
New
Meet Ashanti Finley, Specialist in the People Function team at Berkeley Heights, US. Hear what she has to say about life...
Story, Life at Hikma
06 June 2025
New
Inspiring women of Hikma - Meet Stephanie Haas, Senior Director, Head of Hikma Rx Procurement
Story, Leadership
05 June 2025
Hikma launches Triamcinolone Acetonide Injectable Suspension, USP, in the US
Press Release, Product
05 June 2025
Fitch upgrades Hikma Pharmaceuticals PLC’s long-term issuer default rating to ‘BBB’, outlook stable
Press Release, Corporate
29 May 2025
Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosim...
Press Release, Product
27 May 2025
You have viewed 15 of 514 results